ABCB1 and breast carcinoma: Hypomethylation of the ABCB1 promoter has been detected e.g. in MDR sublines of the human T-cell leukemia cell line CCRF-CEM [26] and the breast cancer cell line MCF-7 [27, 28], obtained by selecting the parental cells for resistance to doxorubicin.